Erik Ostrowski, SVP, CFO, CBO & Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 34,951 shares at $1.39 ($49K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Scheduled sale ($49k) by SVP, CFO, CBO & Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |